Dachaigh › Ailse metastatach › California › Mountain View
Sgrùdaidhean clionaigeach Ailse metastatach ann an Mountain View, CA
Tha 25 sgrùdaidhean airson Ailse metastatach a’ lorg phàirtichean aig làraichean ann agus timcheall air Mountain View (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
A’ fastadhÌre 2
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mìle air falbh
- VA Palo Alto Health Care System, Palo Alto · 5 mìle air falbh
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
A’ fastadhÌre 1/2
- Stanford, Palo Alto · 5 mìle air falbh
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
A’ fastadhÌre 2/3
- Stanford Cancer Center, Palo Alto · 5 mìle air falbh
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A’ fastadhÌre 3
- Palo Alto Medical Foundation - Palo Alto Center, Palo Alto · 5 mìle air falbh
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
A’ fastadhÌre 1/2
- Stanford Medicine, Palo Alto · 5 mìle air falbh
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
A’ fastadhÌre 1
- Stanford Cancer Institute, Stanford · 5 mìle air falbh
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
A’ fastadhÌre 1
- Stanford University Medical Center, Stanford · 5 mìle air falbh
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A’ fastadhÌre 3
- Stanford Women's Cancer Center, Palo Alto · 5 mìle air falbh
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A’ fastadhÌre 3
- Stanford Cancer Center, Palo Alto · 5 mìle air falbh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
A’ fastadhÌre 1/2
- Stanford Cancer Institute, Stanford · 5 mìle air falbh
Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.
A’ fastadhÌre 2
- Stanford University, Palo Alto · 5 mìle air falbh
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
A’ fastadhÌre 3
- Research Site, Palo Alto · 5 mìle air falbh
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
A’ fastadhÌre 1/2
- Stanford Cancer Institute (SCI), Stanford · 5 mìle air falbh
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
A’ fastadhÌre 1
- Stanford Medicine Cancer Center, Stanford · 5 mìle air falbh
FOG-001 in Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- Stanford Cancer Institute, Stanford University, Palo Alto · 5 mìle air falbh
Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases
A’ fastadhÌre 3
- Stanford University School of Medicine, Palo Alto · 5 mìle air falbh
A Study of LY4175408 in Participants With Advanced Cancer
A’ fastadhÌre 1
- Stanford Medicine Cancer Center, Stanford · 5 mìle air falbh
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
A’ fastadhÌre 1/2
- Stanford Cancer Institute, Stanford · 5 mìle air falbh
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
A’ fastadhÌre 2/3
- Stanford Health Care - Skin Cancer Program, Stanford · 5 mìle air falbh
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
A’ fastadhÌre 2/3
- Stanford Cancer Institute, Palo Alto · 5 mìle air falbh
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
A’ fastadhÌre 1
- Stanford Cancer Institute, Stanford · 5 mìle air falbh
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
A’ fastadhÌre 1
- Stanford Cancer Institute, Stanford · 5 mìle air falbh
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
A’ fastadhSgrùdadh amharc
- VA Palo Alto Healthcare System, Palo Alto · 5 mìle air falbh
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
A’ fastadhÌre 1
- Stanford Cancer Institute, Palo Alto · 5 mìle air falbh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Stanford · 5 mìle air falbh
Sgrùdaidhean Ailse metastatach ann am bailtean eile
- Houston, TX104 sgrùdaidhean
- New York City, NY93 sgrùdaidhean
- Nashville, TN70 sgrùdaidhean
- Boston, MA63 sgrùdaidhean
- Los Angeles, CA57 sgrùdaidhean
- St. Louis, MO54 sgrùdaidhean
- Arlington, VA53 sgrùdaidhean
- Philadelphia, PA46 sgrùdaidhean
- Chicago, IL45 sgrùdaidhean
- San Antonio, TX44 sgrùdaidhean
- Washington, DC43 sgrùdaidhean
- Dallas, TX42 sgrùdaidhean
Sgrùdaidhean eile ann an Mountain View
- Aillse (gach seòrsa)40 sgrùdaidhean
- Aillse a' bhroilleach26 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag21 sgrùdaidhean
- Leukemia myeloid geur19 sgrùdaidhean
- Cancer Ovarian19 sgrùdaidhean
- Galar Speactram Autism17 sgrùdaidhean
- Ailseachadh nan Sgamhan17 sgrùdaidhean
- Aillse Prostata15 sgrùdaidhean
- Fàilligeadh a' Chridhe15 sgrùdaidhean
- Autism13 sgrùdaidhean
- Leukemia lymphoblastic geur13 sgrùdaidhean
- Aillse colorectal13 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.